Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 3,921 shares at $200.00 ($784K) on 2020-07-07, disclosed to the SEC on 2020-07-09.
Open-market sale of $784k BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |